Pharma industry Global Business Services: progressions, regressions, and disruptions
Rick Bertheaud and Vicki Phelan discuss how technology, cost, and geopolitics are impacting how life sciences companies are delivering their business services.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Advice Worth Keeping","authorlink":""},"src":"https:\/\/advisory.kpmg.us\/content\/dam\/advisory\/en\/podcast-awk\/pharma-industry-gbs.mp3","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202309\/1bfe45-7ea8-3300-7f0030_800.jpg"},"title":"Pharma industry Global Business Services: progressions, regressions, and disruptions","link":"javascript:;","id":"item-1333411"}]
